Investors Face Deadline in PROCEPT BioRobotics Securities Lawsuit

The securities class action, pending in the United States District Court for the Northern District of California, alleges that PROCEPT executives failed to disclose material information regarding the company's handpiece sales. While the firm previously claimed that sales were largely in line with procedure volume, the company revealed on February 25, 2026, that handpiece sales had actually outpaced procedures every quarter since early 2023. This discrepancy created a backlog of more than 10,000 units in field inventory.

The inventory glut led to a sharp drop in U.S. quarterly handpiece sales, which fell from 13,225 units in the third quarter of 2025 to 9,400 units—a sequential decline of nearly 30%. Consequently, the company missed its annual revenue guidance by millions of dollars. Following these disclosures, PROCEPT shares dropped from $27.84 on February 25, 2026, to $22.69 on February 27, 2026. Investors seeking to serve as lead plaintiffs in Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation must petition the court by the September 22 deadline.